Retinoid Receptors and Therapeutic Applications of RAR/RXR Modulators
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Retinoic acid receptors (RARs) are ligand-controlled transcription factors that function as heterodimers with retinoid X receptors (RXRs) to regulate cell growth, differentiation, survival and death. Due to their regulatory potential, these nuclear receptors (NRs) are major drug targets for a variety of pathologies, including cancer and metabolic diseases. A large amount of RAR- and RXR-selective ligands, ranging from (partial) agonists to antagonists and inverse agonists, have been designed and the corresponding structural and functional analyses have provided deep insight into the molecular basis of ligand action. Ligands regulate, via allosteric conformational changes, the ability of these NRs to interact with different sets of coregulators, which in turn recruit enzymatically active complexes/machineries. Here, we describe strategies in the design of selective RXR and RAR modulators and review the structural mechanisms by which the diverse pharmacological classes of compounds modulate receptor functions. Finally, we discuss the perspectives for retinoid- and rexinoid-based therapies. Keywords: Retinoic acid receptors, retinoid X receptors, agonists and antagonists action, ligand design, selective ligands, structure-function relationship, thee-dimensional structure, therapeutic potential, antagonists rexinoid apoptosis, retinoid- and rexinoid-based therapies
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jones, P. A., & Baylin, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.01.029 · Cited by 4,515
A decade of molecular biology of retinoic acid receptors
Chambon, P. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.9.8801176 · Cited by 2,889 · cited 1×
“RXR is the heterodimerisation partner for a large number of nuclear receptors [134, 140-142] and thus is involved in numerous signalling pathways involved in cell growth and differentiation [1, 143].”
BackgroundThe promise of retinoids to fight against cancer
Altucci, L., & Gronemeyer, H. (2001) · Nature Reviews Cancer · doi:10.1038/35106036 · Cited by 773 · cited 1×
“The development and characterization of highly potent and selective retinoid receptor modulators have provided detailed understanding of their involvement in multiple physiological phenomena and their cancer-therapeutic potential is well documented [4, 5].”
BackgroundSelf-citationInternational Union of Pharmacology. LXIII. Retinoid X receptors
Germain, P., Chambon, P., Eichele, G., Evans, R. M., Lazar, M. A., Leid, M., De Lera, A. R., Lotan, R., Mangelsdorf, D. J., & Gronemeyer, H. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.4.7 · Cited by 496
Self-citationCentral hypothyroidism associated with retinoid X receptor-selective ligands
Sherman, S. I., Gopal, J., Haugen, B. R., Chiu, A. C., Whaley, K., Nowlakha, P., & Duvic, M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904083401404 · Cited by 315 · cited 1×
“4 was shown to exert multiple effects on the hypothalamic-pituitary-thyroid axis [81], but suppressed total T4 levels when administered orally [82].”
BackgroundDissecting the retinoid-induced differentiation of F9 embryonal stem cells by integrative genomics
Mendoza‐Parra, M. A., Walia, M., Sankar, M., & Gronemeyer, H. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.73 · Cited by 91 · cited 1×
“Epigenetic modifications, such as aberrant DNA and histone methylation, are well known to contribute to, or even cause, cancer development and progression[149, 150].”
BackgroundSelf-citationMetabolic Effects of Rexinoids: Tissue-Specific Regulation of Lipoprotein Lipase Activity
Davies, P. J. A., Berry, S. A., Shipley, G. L., Eckel, R. H., Hennuyer, N., Crombie, D. L., Ogilvie, K. M., Peinado-Onsurbe, J., Fievet, C., Leibowitz, M. D., et al. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.2.170 · Cited by 89 · cited 1×
“2a increased TG levels in the ZDF rat [72] and in the apoE2-KI mouse model of mixed dyslipidemia [73], but it had no effect in the C57BL/6J mice [74].”
Background
Cited by
Retinoic acid receptors: From molecular mechanisms to cancer therapy
di Masi, A., Leboffe, L., De Marinis, E., Pagano, F., Cicconi, L., Rochette-Egly, C., Lo-Coco, F., Ascenzi, P., & Nervi, C. (2015) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2014.12.003 · Cited by 403
HOXA5 Counteracts Stem Cell Traits by Inhibiting Wnt Signaling in Colorectal Cancer
Ordóñez-Morán, P., Dafflon, C., Imajo, M., Nishida, E., & Huelsken, J. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.11.001 · Cited by 209
Chakrabarti, M., McDonald, A. J., Will Reed, J., Moss, M. A., Das, B. C., & Ray, S. K. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-150450 · Cited by 57
Docking simulations suggest that all-trans retinoic acid could bind to retinoid X receptors
Tsuji, M., Shudo, K., & Kagechika, H. (2015) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-015-9869-9 · Cited by 19
“Extensive studies on these synthetic compounds have recently been reviewed [3].”
Background
Metadata
- Authors
- le Maire, A., Alvarez, S., Shankaranarayanan, P., R de Lera, A., Bourguet, W., & Gronemeyer, H.
- Venue
- Current Topics in Medicinal Chemistry
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2012-03-01
- Volume
- 12
- Issue
- 6
- Pages
- 505-527
- ISSN
- 1568-0266 (ISSN-L)
- OpenAlex
- W2144458930
- Cited by
- 105
- References
- 7
- FWCI
- 2.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Retinoid Receptors and Therapeutic Applications of RAR/RXR Modulators. https://app.cochat.ai/papers/10.2174/156802612799436687
- The paper
- le Maire, A., Alvarez, S., Shankaranarayanan, P., R de Lera, A., Bourguet, W., & Gronemeyer, H. (2012). Retinoid Receptors and Therapeutic Applications of RAR/RXR Modulators. Current Topics in Medicinal Chemistry. https://doi.org/10.2174/156802612799436687
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.